Texas Retina Associates’ Ashkan Abbey, MD, serves on the editorial board of Retina Specialist, a medical journal focused on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina. In the latest issue, he published a summary of five key posters and presentations from the recent Association for Research in Vision and Ophthalmology (ARVO) meeting. Founded in 1928, ARVO is the largest eye and vision research organization in the world with a membership that includes nearly 12,000 researchers from over 75 countries.
Dr. Abbey’s article highlighted the following recent retina research findings:
- Evidence supporting observation or focal laser for the management of patients with center-involved macular edema with good vision.
- Disorganization of retinal layers showing promise as a biomarker for epiretinal membrane surgery.
- Use of artificial intelligence may transform how retina specialists measure HbA1c and screen for diabetic retinopathy.
- Subcutaneous injection of a mitochondrial agent shows vision gains in patients with dry age-related macular degeneration (AMD).
You can read Dr. Abbey’s full article here.